Perioperative Management of a Patient Taking Suboxone® at the Time of Ambulatory Surgery

In 2016, more than 11 million people reported misuse of opioids in the previous year. In an effort to combat opioid use disorder (OUD), the use of agonist/antagonist is becoming increasingly common, with more than 2.2 million patients reporting use of a buprenorphine containing medication such as Su...

Full description

Saved in:
Bibliographic Details
Published inCase reports in anesthesiology Vol. 2020; no. 2020; pp. 1 - 5
Main Authors Malan, Shawn H., Khurmi, Narjeet, Bailey, Christopher H.
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Publishing Corporation 2020
Hindawi
John Wiley & Sons, Inc
Hindawi Limited
Wiley
Subjects
Abdomen
Ambulatory care
Analgesics
Anesthesia
Bupivacaine
Buprenorphine
Care and treatment
Case Report
Case reports
Dexmedetomidine
Fentanyl
Hernias
Laparoscopy
Narcotics
Pain
Patients
Surgery
Surgical clinics
United States > US
Online AccessGet full text

Cover

More Information
Summary:In 2016, more than 11 million people reported misuse of opioids in the previous year. In an effort to combat opioid use disorder (OUD), the use of agonist/antagonist is becoming increasingly common, with more than 2.2 million patients reporting use of a buprenorphine containing medication such as Suboxone®. Buprenorphine is a unique opioid which acts as a partial μ agonist and ĸ antagonist. These properties make it an effective tool in treating OUD and abuse. However, despite its advantages in treating OUD and abuse, buprenorphine can make it difficult to control acute perioperative pain. We present a case in which the Mayo Clinic Arizona protocol for patients undergoing minimally invasive ambulatory surgery while taking Suboxone® is successfully executed, resulting in adequate postoperative pain control and timely discharge from the postanesthesia recovery unit.
Bibliography:Academic Editor: Renato Santiago Gomez
ISSN:2090-6382
2090-6390
DOI:10.1155/2020/5628348